0001104659-17-050275.txt : 20170808
0001104659-17-050275.hdr.sgml : 20170808
20170808162412
ACCESSION NUMBER: 0001104659-17-050275
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170804
FILED AS OF DATE: 20170808
DATE AS OF CHANGE: 20170808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Golubieski John
CENTRAL INDEX KEY: 0001610695
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 171015123
MAIL ADDRESS:
STREET 1: C/O LANTHEUS HOLDINGS, INC.
STREET 2: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: NY
ZIP: 01862
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25 BROADWAY, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
BUSINESS PHONE: 212-203-5072
MAIL ADDRESS:
STREET 1: 25 BROADWAY, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
3
1
a3.xml
3
X0206
3
2017-08-04
1
0001579428
Axsome Therapeutics, Inc.
AXSM
0001610695
Golubieski John
25 BROADWAY, 9TH FLOOR
NEW YORK
NY
10004
0
1
0
0
Chief Financial Officer
/s/ John Golubieski
2017-08-08